Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

Virtus Pharmaceuticals, Llc Recalls Several Lots of Virt-Nate Prenatal/Postnatal, Prescription Folate-Containing Dietary Supplement
irtus Pharmaceuticals, Llc is recalling several lots of Virt-Nate Prenatal/Postnatal, Prescription Folate-Containing Dietary Supplement. The following lot numbers are being recalled because the tablets in these lots were imprinted with the incorrect code: Lot code M143810A, exp 7/2017, NDC 69543-264-10, UPC 369543264105, and Lot code M143810, exp 7/2017, NDC 76439-264-10, UPC 376439264109 Virt-Nate Prenatal/Postnatal, Prescription Folate-Containing Dietary Supplement is commonly used as a dietary supplement for pre and post pregnancy. Folate is also sold under other brand names. This recall alert only applies to the select lots of Virt-Nate Prenatal/Postnatal, Prescription Folate-Containing Dietary Supplement. No other prenatal vitamin products were involved in this recall. To search for and view the FDA notice about this recall, please visit: http://www.accessdata.fda.gov/scripts/ires/index.cfm
Learn More

Teva Pharmaceuticals USA, Inc. a Singlel Lot of Paricalcitol Capsules, 1 mcg
Teva Pharmaceuticals USA, Inc. is recalling a single lot of Paricalcitol Capsules, 1 mcg. The following lot number is being recalled because of this lot did not pass the manufacturer's routine tests for impurities and by-products from breakdown over time: 13013.009A Paricalcitol is used in the treatment of overactive parathyroid gland in people with kidney disease. This recall alert only applies to the single lot of the generic Paricalcitol Capsules, 1 mcg made by Teva Pharmaceuticals USA, Inc. No other paracalcitol products were involved in this recall. To view the FDA notice about this recall, please visit: http://www.accessdata.fda.gov/scripts/ires/index.cfm
Learn More

Date Published Title Drug Source
2016-07-06 Virtus Pharmaceuticals, Llc Recalls Several Lots of Virt-Nate Prenatal/Postnatal, Prescription Folate-Containing Dietary Supplement Prenatal Vitamins FDA
2016-07-06 Teva Pharmaceuticals USA, Inc. a Singlel Lot of Paricalcitol Capsules, 1 mcg Paricalcitol FDA
2016-07-06 Teva Pharmaceuticals USA Recalls Single Lot of Nabumetone 750 mg Tablets Nabumetone FDA
2016-07-06 AstraZeneca Pharmaceuticals LP Recalls Select Lots of Tudorza Pressair, 400 mcg per actuation Aclidinium FDA
2016-07-06 Safecor Health, LLC Recalls Single Lot of Donnatal Elixir Donnatal FDA
2016-07-06 Pfizer Inc Recalls Single Lot of Adult Robitussin PEAK COLD Cough & Chest Congestion DM Liquid 8 oz. Bottle Guaifenesin with Dextromethorphan FDA
2016-06-01 FDA warns about rare but serious skin reactions with mental health drug olanzapine Fluoxetine with Olanzapine FDA
2016-06-01 FDA Warns Ketoconazole Should Not Be Prescribed for Skin and Nail Infections Ketoconazole FDA
2016-06-01 Clinical Trial Results Finds Increased Risk of Leg and Foot Amputations with Use of Canagliflozin (Invokana, Invokamet) Canagliflozin / Metformin FDA
2016-06-01 FDA Advises Avoiding Use of Fluoroquinolone Antibiotics in Certain Uncomplicated Infections Due to Disabling Side Effects That Can Occur Gemifloxacin FDA
2016-05-02 FDA Expands Use of Metformin-Containing Drugs in Certain Patients with Reduced Kidney Function Glipizide with Metformin FDA
2016-05-02 FDA Is Reviewing a Study Linking Fluconazole Use and Risk of Miscarriage Fluconazole FDA
2016-02-03 Los Profesionales Sanitarios Informados: Viekirax (Ombitasvir, Paritaprevir, Ritonavir) No Recomendado En Pacientes Con Determinados Problemas En El Hígado AEMPS
2015-11-12 FDA Completes Review of Blood-Thinning Medicine Plavix (Clopidogrel) Clopidogrel FDA
2015-08-28 FDA Warns About Possible Side Effect of DPP-4 Inhibitors Sitagliptin FDA
2015-08-25 Allergan Issues Voluntary Recall of Select Lots Of REFRESH Lacri-Lube, REFRESH P.M., FML, and Blephamide Over Safety Concerns Fluorometholone FDA
2015-05-27 FDA Warns About Possible New Side Effect of SGLT2 Inhibitors Canagliflozin / Metformin FDA
2015-03-05 FDA Cautions About Using Testosterone Products for Low Testosterone Due to Aging; Possible Increased Risk of Heart Attack and Stroke Methyltestosterone FDA
2014-12-11 FDA Warns Ziprasidone (Geodon) May Cause Rare but Serious Skin Reactions Ziprasidone FDA
2014-11-26 FDA Warns About Case of Progressive Multifocal Leukoencephalopathy (PML) With MS Drug Tecfidera (Dimethyl Fumarate) Dimethyl Fumarate FDA